” I do think there’s a number of areas that are going to be changes for 2025 and fairly progression from this year”, says Preeya Beczek, managing director and co-founder of Beczek. COM Ltd, a practitioner in governmental politics and compliance. ” There’s a real focus on personalizing detail treatments, including cell and gene therapies, and, you know, there’s expected to be quite a big trend in this area to really focus on the personal part of that”.
Also, there has been a lot of talk from business about electronic manufacturing and using cloud-based systems to improve effectiveness, Beczek continues. And, going hand-in-hand with the data-driven method is the ability for businesses to realize the potential return on investment for their R&, D work, she adds. ” It’s definitely looking at that end to end, moving away from practical warehouses to looking at the R&, D end to end, which I find extremely interesting, basically, because it can really improve health outcomes and really help organizations to focus on the patient”, Beczek says.
A key trend for 2025 will be artificial intelligence ( AI), Beczek specifies. ” I think we’re just going to have lot more people adopting]Generative AI and ] that way of working, in their day-to-day work”, she says. ” I think that there’s going to be some push to get speed, ]in ] things like manufacturing timelines, ]so] they become shorter”.
Press above to see the whole interview
About the speech
Preeya Beczek is Director of Beczek Consulting
Preeya Beczek is Beczek’s Managing Director and co-founder. COM Ltd, a practitioner in governmental politics and compliance. Preeya has spent more than 25 years working in the governmental affairs and compliance field, specializing in both operational and strategic regulatory affairs activities. Due to her present position, Preeya worked in industry performing a lot of equipment and process development to assist companies with new systems, initiatives with AI automation, regulation, information management, system software modernization, and so on.